Section Navigation
Section Navigation
- Module 6 Overview
Treatment of Key Populations and Unique Situations - 0%Lesson 1
Treatment of HCV in Persons with HIV CoinfectionActivities- 0%Lesson 2
Treatment of HCV in Persons with Renal ImpairmentActivities- 0%Lesson 3
Treatment of HCV in Persons with Substance UseActivities- 0%Lesson 4
Treatment of HCV in a Correctional SettingActivities- 0%Lesson 5
Management of Health Care Personnel Exposed to HCVActivities- 0%Lesson 6
Perinatal HCV TransmissionActivitiesLesson 3. Treatment of HCV in Persons with Substance Use
Learning Objective Performance Indicators
- Discuss the prevalence of substance use among persons in the United States
- Describe HCV treatment responses in persons with substance use disorders compared with those who do not have substance use disorders
- Summarize HCV treatment eligibility in persons who have a past or current substance use disorder
- List support services and management strategies for persons with substance use disorders who have chronic HCV infection
- Explain the concept of HCV reinfection in persons who inject drugs
About this Lesson
Learning Objective Performance Indicators
- Discuss the prevalence of substance use among persons in the United States
- Describe HCV treatment responses in persons with substance use disorders compared with those who do not have substance use disorders
- Summarize HCV treatment eligibility in persons who have a past or current substance use disorder
- List support services and management strategies for persons with substance use disorders who have chronic HCV infection
- Explain the concept of HCV reinfection in persons who inject drugs
Activities in this Lesson
Share by e-mail
Check
-On-
Learning
QuestionsThe Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your understanding of key concepts.You must be signed in to customize your interaction with these questions.
- 0%Lesson 2
Funded by
Centers for Disease Control and Prevention Cooperative Agreement (CDC-RFA-PS21-2105)
Created at
University of Washington
Part of
IDEA Platform
CME provided byUniversity of Alabama Birmingham
CNE provided byUniversity of Washington School of Nursing
Copyright © 2024 Hepatitis C Online
Since you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: nhcvc-master-9e0a1e65-2024-12-09-232944